INS and type 2 diabetes mellitus: There were no hypoglycemic episodes (the glucose level less 3.9 mmol/L) in the patients with T2DM in both subgroups, which proved that both the insulin pump therapy and bolus insulin therapy were safe in the early follow-up periods.